127 related articles for article (PubMed ID: 8638523)
1. New insights into mechanisms underlying nitrate tolerance.
Münzel T; Kurz S; Heitzer T; Harrison DG
Am J Cardiol; 1996 May; 77(13):24C-30C. PubMed ID: 8638523
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a role of oxygen-derived free radicals and protein kinase C in nitrate tolerance.
Münzel T; Harrison DG
J Mol Med (Berl); 1997; 75(11-12):891-900. PubMed ID: 9428622
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance.
Kurz S; Hink U; Nickenig G; Borthayre AB; Harrison DG; Münzel T
Circulation; 1999 Jun; 99(24):3181-7. PubMed ID: 10377083
[TBL] [Abstract][Full Text] [Related]
4. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo.
Münzel T; Bassenge E
Circulation; 1996 Jun; 93(11):2052-8. PubMed ID: 8640982
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying nitrate-induced endothelial dysfunction: insight from experimental and clinical studies.
Warnholtz A; Tsilimingas N; Wendt M; Münzel T
Heart Fail Rev; 2002 Oct; 7(4):335-45. PubMed ID: 12379819
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance.
Münzel T; Giaid A; Kurz S; Stewart DJ; Harrison DG
Proc Natl Acad Sci U S A; 1995 May; 92(11):5244-8. PubMed ID: 7539147
[TBL] [Abstract][Full Text] [Related]
7. Explaining the phenomenon of nitrate tolerance.
Münzel T; Daiber A; Mülsch A
Circ Res; 2005 Sep; 97(7):618-28. PubMed ID: 16195486
[TBL] [Abstract][Full Text] [Related]
8. Melatonin inhibits nitrate tolerance in isolated coronary arteries.
O'Rourke ST; Hammad H; Delagrange P; Scalbert E; Vanhoutte PM
Br J Pharmacol; 2003 Aug; 139(7):1326-32. PubMed ID: 12890712
[TBL] [Abstract][Full Text] [Related]
9. The effect of peroxynitrite decomposition catalyst MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates: role in nitrate tolerance.
Mollace V; Muscoli C; Dagostino C; Giancotti LA; Gliozzi M; Sacco I; Visalli V; Gratteri S; Palma E; Malara N; Musolino V; Carresi C; Muscoli S; Vitale C; Salvemini D; Romeo F
Pharmacol Res; 2014 Nov; 89():29-35. PubMed ID: 25174989
[TBL] [Abstract][Full Text] [Related]
10. Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production.
Münzel T; Mollnau H; Hartmann M; Geiger C; Oelze M; Warnholtz A; Yehia AH; Förstermann U; Meinertz T
J Am Coll Cardiol; 2000 Aug; 36(2):628-34. PubMed ID: 10933381
[TBL] [Abstract][Full Text] [Related]
11. Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction.
Münzel T; Steven S; Daiber A
Vascul Pharmacol; 2014 Dec; 63(3):105-13. PubMed ID: 25446162
[TBL] [Abstract][Full Text] [Related]
12. Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance.
Dikalov S; Fink B; Skatchkov M; Stalleicken D; Bassenge E
J Pharmacol Exp Ther; 1998 Aug; 286(2):938-44. PubMed ID: 9694953
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator effect and tolerance induced by the nitrocompound SIN-1 in rabbit femoral artery.
Govantes C; Rodríguez-Martínez MA; Marín J
Methods Find Exp Clin Pharmacol; 1996; 18(6):387-95. PubMed ID: 8892268
[TBL] [Abstract][Full Text] [Related]
14. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
Knorr M; Hausding M; Kröller-Schuhmacher S; Steven S; Oelze M; Heeren T; Scholz A; Gori T; Wenzel P; Schulz E; Daiber A; Münzel T
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2223-31. PubMed ID: 21757654
[TBL] [Abstract][Full Text] [Related]
15. Nitroglycerin tolerance: different mechanisms in vascular segments with or without intact endothelial function.
Gruhn N; Boesgaard S; Andersen C; Aldershvile J
J Cardiovasc Pharmacol; 2002 Aug; 40(2):201-9. PubMed ID: 12131549
[TBL] [Abstract][Full Text] [Related]
16. [Why does nitroglycerin tolerance appear?].
Włodek L; Sokołowska M
Postepy Hig Med Dosw; 2001; 55(5):673-85. PubMed ID: 11795202
[TBL] [Abstract][Full Text] [Related]
17. The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine.
Daiber A; Mülsch A; Hink U; Mollnau H; Warnholtz A; Oelze M; Münzel T
Am J Cardiol; 2005 Oct; 96(7B):25i-36i. PubMed ID: 16226933
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia.
Abrams J
Am J Cardiol; 1992 Sep; 70(8):30B-42B. PubMed ID: 1529924
[TBL] [Abstract][Full Text] [Related]
19. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
Mülsch A; Busse R; Bassenge E
Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
[TBL] [Abstract][Full Text] [Related]
20. Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved?
Fung HL
Annu Rev Pharmacol Toxicol; 2004; 44():67-85. PubMed ID: 14744239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
